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Enabling the high-throughput biological assays requires a favorable biomimetic 
environment with appropriate biochemical and biomechanical conditions. Microfluidic 
devices are capable of establishing the desired chemical and mechanical conditions over 
cell samples in a scale-down version of a lab. The ability to generate chemical and 
mechanical gradients in microfluidic chips is important for creating a biomimetic 
environment that enables high-throughput biological assays. However, there is still a 
significant knowledge gap in the generation of both mechanical and chemical gradients in 
a single device, limiting the reach of biological assays in microfluidic chips. In the 
present study, we designed and developed a platform for gradient generation in 
microfluidic circuits with integrated microchambers.  The embedded microchambers 
allows cell culture and provides a reactive microenvironment where chemical and 
mechanical gradients are introduced to the cultured cells. This novel design is capable of 
providing two dimensional (2D) and three dimensional (3D) drug screening studies over 
the cultured cells. Specifically, a chemical gradient is generated across the 
microchambers, exposing cells to a uniform concentration of molecules. In the case of the 
2D cell culture, this design is capable of producing a mechanical gradient in the form of 
varied shear stresses upon cells in different microchambers and within the same 
 
microchamber. Cells seeded within the chambers remain viable and show normal 
morphology throughout the culture time. To validate the effect of different drug 
concentrations and shear stresses in 2D cell culture, doxorubicin, an anti-cancer agent, 
was flowed into chambers seeded with skin cancer cells (A431 cells, epidermoid 
carcinoma) at different flow rates (from 0 to 0.2 µl/min). The experimental results show 
that increasing doxorubicin concentration (from 0 to 30 µg/ml) within chambers not only 
prohibits cell growth but also induces a significant increase in cell death. In addition, the 
increased shear stress (0.005 Pa) at high flow rates poses a synergistic effect on cell 
viability by inducing cell damage and detachment. For 3D cell culture, the design was 
modified for integration with 3D cell encapsulation and 3D tissue printing within the 
microchambers. This ability was used for introducing a gradient of the insulin-like 
growth factor 1 (IGF-1) for the differentiation of the skeletal muscle myoblast into 
myotubes. The myogenesis results show that cells in the microfluidic devices have a 
faster pace of differentiation as compared to static culture conditions in a petri dish. 
Collectively, these studies demonstrate the potential of microchamber-embedded 
microfluidic gradient generators in 2D and 3D cell culture, high-throughput drug 
screening, and as a 3D tissue engineering platform.
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1 Chapter 1: Introduction 
Microfluidics is the manipulation of fluids in a small volume 1. Over the past few 
decades, we have witnessed a significant growth in the development and fabrication of 
microfluidic devices. Various technologies and functionalities have been introduced into 
microfluidic devices, making them even more powerful and versatile in their biomedical 
applications, particularly in tissue engineering1. Due to their wide selection of capability 
and small scale, these microfluidic devices are low cost, low reagent consumption, 
portable, and are capable of integration with other devices, including high resolution 
imaging systems. Microfluidic devices can provide chemical, mechanical, and electrical 
stimuli on the samples 2, 3. Finally, microfluidics has shown the potential for cell culture 
using the patterning of extracellular matrix (ECM) within the devices, and they are also 
able to temporally and spatially control the fluidic flow inside microchannels with the 
cell culture, affording new possibility for the investigation of the microenvironment 
effect on cultured cells 4, 5.  
Microfluidic devices are compatible with various types of cells and they can 
mimic different physiological stimuli for cell studies, and these conditions are 
comparable to in vitro studies, leading to the replication of the in vivo microenvironment 
for studying different condition in the scale of tissues and organs on a microfluidic chip 6. 
One of the benefits of a microfluidic device is the stable nutrient supplies and by-product 
removal from the samples with the controlled fluid flow 7. Further, fluid flow can mimic 
the in vivo conditions of the native organ vasculature system 8.  
In the past decade, gradient generators were introduced in microfluidic designs 
and these devices are able to produce chemical and physiological gradients over 
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designated areas within the microfluidic device where cultured cells can be exposed to 
the gradients. Here in this chapter, an introduction of the organ-on-a-chip platforms, 
chemical gradient generator devices, and the studies of mechanical and chemical stimuli 
on the microfluidic devices are covered.  
1.1 Organ-On-A-Chip 
Organs-on-a-chip is a type of microfluidic device that can create an environment 
for culturing live cells by perfusing nutrient media to mimic and stimulate tissue and 
organ physiology. These devices are able to recreate in vitro tissue-tissue interaction, 
vascular perfusion, and multicellular communication 9. Conventional 2D cell culture 
cannot support the physiologically relevant tissue proliferation and differentiation 
functions, and thus is unable to predict in vivo tissue functioning 10. Therefore it is 
necessary to employ better tissue and organ models with the development of co-culturing 
and 3D culturing cell models.  
1.1.1 3D cell culture and co-culture of Organ-on-a-chip 
Organ-on-a-chip devices are capable to mimic the physiological function of 
tissues and organs in a microenvironment with fluidic perfusion. These devices are able 
to recapitulate the minimal function of tissues and organs. The simplest design of these 
devices can contain one type of cell in a single channel and mimic a single tissue 
function. In some other designs of organ-on-a-chip devices, they can contain more than 
one type of cells in the microchannel that is separated by a porous membrane, and each 
side of the membrane represents a different tissue. The example of these devices include 
lung-on-a-chip 11, kidney-on-a-chip 12, and blood-brain-barrier devices13. In addition, 
cells can be cultured in parallel channels separated by a porous medium or hydrogel, 
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which acts as a membrane for the diffusion of the molecules or cellular migration. These 
devices are able to apply physical forces such as shear stress, compression force, and 
cyclic strain on the cultured organs. In addition, these devices are compatible for drug 
screening and for studying environmental perturbation; and these studies can be 
conducted by culturing tissues in a microchannel that is connected to another 
microchannel filled with other cell lines. Finally, by connecting several organ-on-a-chip 
devices with different tissue types, a body-on-a-chip is created to study the physiological 
interaction of multiple tissues in comparison with in vitro studies. 
3D cellular models have been used for studying tissue functions for different 
disease models. However, these methods have some drawbacks, as they are difficult to 
fabricate and difficult to analyze the encapsulated cells. In addition, since they are 
encapsulated within hydrogel structures, they would not expose to mechanical cues such 
as fluid shear stress, tension, and compression 14. Moreover, in 3D tissue study, due to the 
absence of fluidic flow, the study of the interaction of circulating blood and immune cells 
on cultured tissue is often limited. To overcome these limitations, organ-on-a-chip 
devices can compensate the drawbacks of conventional 3D culturing of cells 9.  
1.1.2 Scaffolds in Organ-on-a-chip 
3D cell culture relies on cellular scaffolds, and especially hydrogels, which are 
hydrophilic crosslinked polymers and can absorb water many times of their original 
mass. They have been widely used for tissue engineering studies for cellular 
differentiation 15, migration, and proliferation 16. The characteristics of hydrogels are 
related to their components, crosslinking method, and polymerization processes. There 
has been a wide range of hydrogels from natural and synthetic polymers with different 
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methods of crosslinking. Hydrogels are designed to provide 3D cellular support for tissue 
growth17, and they have been used for various biomedical applications such as drug 
delivery, tissue adhesion, and regenerative medicine 18. The organ-on-a-chip devices are 
capable of integration with 3D scaffolds and cellular encapsulation within the hydrogels. 
In that case, cells are not cultured on a 2D surface, rather cells are encapsulated in a 
hydrogel scaffold. This method and technique can mimic the physiologically relevant 
models of native tissues for in vitro studies. For instance, in the study of skeletal muscle-
on-a-chip, the architectural and structural of three-dimensional skeletal muscle tissues 
have been recapitulated within microfluidic devices. Moever, 3D photo-patterning has 
been been used to fabricate micropillars and crosslink the encapsulated cells within 
gelatin methacryloyl (GelMA), micropillars serve as an anchoring site for the 
encapsulated muscle tissue and is used to measure the passive tension of skeletal muscle 
bundles 19.  
Sometimes the inadequacy of animal models for evaluating the toxicity of drug 
compounds can lead to in vitro models which can mimic the in vivo environments. The 
liver-on-a-chip platform was developed for toxicity assessment and the microfluidic 
design was used as a bioreactor that can be integrated with a 3D bioprinter for the 
fabrication of a 3D scaffold of liver tissues 20. This device was the integration of 3D 
bioprinting with the microfluidic devices, which lead to the fabrication of small-scale 
bioreactors to serve an organ-on-a-chip device. Other techniques were combined with 
organ-on-a-chip devices, and these techniques were used in a new method for generating 
a human induced pluripotent stem cells (hiPSCs) brain organoids by mimicking the 
environment that is favorable for brain development. In situ neural differentiation and 
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organization of brain organoids were studied for modeling brain development and 
diseases 21. Organ-on-a-chip devices have been applied for investigating stem cell 
differentiation to specific lineages and the differentiation process, stem cells that have 
been used for the studies were embryonic stem cells22, induced pluripotent stem cells 
(iPSC) 23, mesenchymal stem cells23, and neural stem cells24. 
1.1.3 Fabrication of Organ-on-a-chip devices 
Soft lithography is a common method for fabricating microfluidic devices. In this 
method, microfluidic channels are etched onto silicon wafers, and uncured PDMS covers 
the surface of the wafer for molding. After chemical or photo-crosslinking, the PDMS 
based microfluidic channel can peel from the silicon wafer. PDMS is often used as a 
substrate in which they can be chemically treated and coated with ECM proteins to 
provide chemical bonding between cells and the PDMS substrate as well as between 
hydrogels to the PDMS substrate 6. One of the major advantages of using PDMS for 
microfluidic device fabrication is the transparency of the material, and this feature allows 
real-time and high-resolution imaging from the device to observe cellular responses to the 
chemical and mechanical stimuli within the device. 
Working with microfluidic devices provides control over the parameters of the 
experiment which is not easily controlled in conventional cell culturing and bioreactors. 
These devices can be integrated with microsensors which can inform the real-time 
conditions of cultured cells. The microsensors have been used for analyzing cell 
migration 25, fluidic flow pressure 26, and some other conditional parameters. The 
flowrate of the liquid medium is one of the parameters that can be regulated within 
microfluidic devices. Because of the dimension of the microfluidic channels, the flow 
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inside the channels is laminar and this can lead to control of the chemical and mechanical 
gradients. This flow control has been exploited in noninvasive study of  nerotoxin27, in 
studies of cellular differentiation and cell-cell junction integrity28. One of the other 
features of microfluidic devices is that the fluidic shear stress can be controlled 
independently from the chemical gradient. This can be applied by altering the flowrates 
or channel dimensions 6, 13, and by separating the cellular channel from the chemical 
gradient channel 12. The final advantage of microfluidic devices is the control over the 
cell patterning. Cellular pattering can occur by laminar stream of fluidic flow for placing 
cells and ECM 29, by designing microchannel patterns that lead to cellular patterning 30, 
and by pretreating the substrate with the ECM proteins 31, 32.  
1.1.4 Applications of Organ-on-a-chip 
Microfluidic devices can be integrated with a porous substrate which can divide 
the parallel channels and this design can be used for tissue barrier function studies, which 
in this studies two types of cells cultured on two sides of the membrane and they create a 
cell-cell interface that can mimic the endothelial vascular interaction with other tissues 11, 
33-35. The next step for this technology is to connect the couple of the organ-on-a-chip 
devices together and create a body-on-a-chip. This method could give researchers 
opportunities to investigate the effect of the different organs on each other for drug 
discovery and development. It is an important aspect of the devices to combining two or 
more different tissues to address the functionality of the organ-on-a-chip devices 9.  
A human blood-brain-barrier (BBB) was developed as an organ-on-a-chip device 
by culturing human brain microvascular endothelium on one side of the fibronectin-
coated polycarbonate membrane and human astrocytes on the other side of the membrane 
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35. Using this device the trans-epithelial electrical resistance (TEER) across the barrier 
was measured. It was found that the TEER level on the device was higher than the TEER 
on conventional culturing of the cells on the polycarbonate membrane. This technique 
was used for studying BBB drug transportation across the tissues through the membrane. 
Organ-on-a-chip devices were used for studying the neurovascular tissues by culturing rat 
brain microvascular endothelial cells on one side of a porous membrane and astrocytes, 
neurons and microglia were cultured on the other side of the membrane. On this device, 
neuroinflammation was studied with TNF-α, which activated adjacent microglia and 
astrocytes and the result of this study was similar to the neuroinfectious disease that had 
studied in vivo 36. In other studies, mouse embryonic stem cell-derived motor neurons and 
C2C12 myotubes were cultured for studying the formation of Synapse at the 
neuromuscular junctions 37.  
The alveolar-capillary interface was recapitulated using a lung-on-a-chip device. 
In this device, lung microvascular endothelial cells were cultured on the bottom side of 
the porous membrane, and at the top channel, alveolar epithelial cells were cultured. In 
this device, two hollow channels on both sides of the cultured microchannel applied the 
cyclic strain by producing a suction inside the channels, and this strain mimics the 
breathing motion of the lung on cultured tissue 38. This lung-on-a-chip device introduces 
a new level of functionality of the organ-on-a-chip as it was able to house multiple cell 
lines and apply mechanical forces for mimicking the breathing motion. The induction of 
pulmonary vascular permeability and lung edema was examined by perfusing the cancer 
drug interleukin-2 (IL-2) through the vascular channel on the lung-on-a-chip device. This 
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model was used for studying pulmonary edema which the condition that there are fluid on 
the lungs 11. 
Furthermore, organ-on-a-chip devices were used for developing a model for 
cancer studies in systems called cancer-on-a-chip. In one study, the co-culturing of 
human mammary epithelial cells with human mammary fibroblasts resulted in a breast 
cancer model, which was used to investigate the effect of direct cell contact on the 
transition from ductal carcinoma in situ to invasive ductal carcinoma 39, 40. With the 
benefit of culturing multiple cells and analyzing the result of culturing lung 
adenocarcinoma cells in a high-throughput organ-on-a-chip, the study showed that tumor-
cell growth was sensitive to TGF-β inhibitor drugs in 3D microenvironments but not in 
monolayer culture 41. 
1.2 Chemical gradient generation devices 
The length scale of microfluidic devices and the availability of many user-defined 
designs, combined with microfluidic handling capabilities, make them ideal platforms for 
drug screening42, 43, and microfluidic bioassays44. Generation of spatial and temporal 
chemical gradients in microfluidic devices has been widely reported to study the efficacy 
and toxicity of drugs45 and examine their effects on cellular behaviors, such as cell-
substrate adhesion46, cancer metastasis47, angiogenesis48, and stem cell differentiation49. 
In addition, versatile gradient generation methods also provide a convenient solution for 
various immunoassays50, 51. Moreover, they have been widely adopted in studying 
bacterial chemotaxis activities52-56.  
Controlling biological and pathological processes such as cancer cell metastasis 
57, axon guidance 58, wound healing 59, drug screening 6, and microfluidic bioreactor 20can 
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be monitored using a gradient of concentrations 60. These studies can be conducted using 
in vitro dishes. However, the consumption of the chemical and the production of the 
byproduct from the living cells and tissues can affect the result of the research. On the 
other hand, microfluidic devices can produce a robust and continuous concentration over 
the samples during the study. Microfluidic devices based on their purpose of the study 
can run with a fluidic flow condition or diffusion condition for generating a gradient of 
concentrations. The gradient was engaged in studies such as differentiation, cellular 
migration, cell growth, and apoptosis of cells 6, 61. 
Microfluidic devices can generate a stable and robust gradient, these devices can 
be categorized into two major groups: flow-based microfluidic and diffusion-based 
microfluidic 60 (Table 1). Flow-based microfluidic gradient generations consist of a 
serpentine microchannel which can produce a chaotic flow and passively enhance the 
mixing procedure inside the microchannels 62. In this design, the gradient is in a 
perpendicular direction to the fluid flow, and the concentration domain can be changed 
by changing the flowrates at the inlets of the device. In addition, these devices have some 
limitations in the culturing site and control on shear stress due to the fluidic flow, which 
can affect the results and limit type of the studies that these devices can perform. 
Type application Research purpose Ref. 
Flowed-based 
microfluidic 
Stem cell differentiation Differentiation into astrocytes of human neural stem cells 24 
Growth and death of mouse neural stem cells 63 
Growth of human mesenchymal stem cells 64 
Endothelial cell migration Cell migration in response to VEGF-A gradients 65 
Call attachment on PEG-RGDS gradients 66 
Cancer chemotaxis EGF gradient sensing of breast cancer cells 67 
10 
Doxorubicin gradient effects on cell apoptosis 6 
EGF receptor-cell motility study 68 
Neutrophil chemotaxis Dynamic IL-8 gradient 69 
IL-8, LTB4 overlapping gradient 70 
Chemoattractant–receptor interaction 71 
Axon guidance Growth cone behavior of chick retinal ganglion neurons in 
response to ephrinA5 gradients 
72 
Organ-on-a-chip Measurement of trans-epithelial electrical resistance 
(TEER) 
35 
ECM patterning for tissue studies 29 
Diffusion-based 
microfluidic 
Stem cell differentiation Human embryonic stem cell culture on a membrane-based 
chip 
73 
Endothelial cell migration Capillary formation of human adult dermal endothelial 
cells in collagen gels 
74 
Capillary growth in co-culture with cancer and endothelial 
cells 
75 
Cancer chemotaxis FBS gradient-induced cell migration 76 
Cancer migration in response to EGF gradients 77 
Cancer migration restrained by an MMP inhibitor 78 
Neutrophil chemotaxis Dynamic gradient-induced desensitization of human 
neutrophils 
79 
Human neutrophils in EGF gradients of collagen gels 77 
Organ-on-a-chip Mimicking the breathing function 38 
Effect of TGF-b and TGFbR2 inhibitor drugs on cancer 
growth 
41 
Table 1.  
Mixing solutions and generating chemical gradients is an important area that has 
triggered numerous research activities in microfluidic device design and development. 
The most common method for generating chemical gradients in microfluidics is by 
mixing inlet streams containing controlled concentrations of chemicals in 
microchannels80, and one of the common approaches arranges the microchannels in a 
serpentine shape81. By varying the concentration and flow rate of each microchannel 
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inlet, these so-called “Christmas tree-like” microfluidic networks can generate a profile 
of chemical gradients at the outlet region82, 83. This outlet region is normally populated 
with different types of cells to receive the chemical gradients and to observe the 
response84. These types of devices have been used to study the proliferation and 
differentiation of neural stem cells85, migration of breast cancer cells86, colon cancer cells 
87, and toxicity effect of air pollutants on lung cancer cells88. Nevertheless, this design has 
only one culture compartment that can be used to investigate the response of the cultures 
to chemical gradients. Further, microfluidic devices have been extensively used as high-
throughput systems in a way that cellular responses to several conditions can be tested on 
a single chip 89, 90. However, these high-throughput systems cannot produce different 
conditions automatically and rely on a secondary system for the preparation of the 
culturing environment91.  
Christmas tree-liked microfluidic channel was used as a gradient generator in 
different applications 92. This design consists of a series of serpentine-shaped channels 
that can produce a uniform gradient in the outlet chamber. Depending on the domain of 
the concentration gradient and the combination of the molecules, this design can have 
multiple inlets for flowing solutions into the microfluidic device, and the gradient of the 
molecules and solution will be produced at the outlet. Modification on the Christmas tree-
like design can result in a flowrate independent gradient generator which can handle 
higher flowrate. It was used for electrophoresis for the separation or concentration of 
fluorophores 93. In addition, Christmas tree-like designs were used for generating 
dynamic temporal and spatial concentration gradients by controlling the flowrates at 
inlets of devices 6, 94.  
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Concentration gradient of multiple chemicals can be used for studying the 
combined biochemical effects on cells, tissues, and organs. To produce the durable 
gradient over the samples in microfluidic devices, complex designs are able to produce 
double gradients95, triple gradient96, and multiple gradients within a single chip for 
screening applications. In addition, these gradient generations can be linear 97 and 
nonlinear 98 across the chamber of the microfluidic device. 
Microfluidic devices have been used for studying hypoxia on 2D cell culture by 
producing a gradient of oxygen over the samples 99. In addition, single cell signaling 
using hydrodynamic strategies by modulating the flow frequency and mimicking the 
extracellular microenvironment using gradient generator was studied 100. Besides, 
microfluidic gradient generators have been used to quantify the effects of flow on cell 
migration during chemotaxis 101. Some studies using microfluidic devices enable the 
control of cell interaction with extracellular microenvironment, such as a surface with 
desirable gradients on PDMS substrates produced by gradient generators 102.  
Cellular response study under the fluidic condition using microfluidic devices is 
comparable to the chemical nonhomogeneities that are occurring in vivo 97. However, the 
biological result from these devices can be limited, as the biological assays are designed 
for conventional petri dish and not for microfluidic devices. Most of the microfluidic 
devices have a limitation on the throughput of the result from the drug testes and 
physiological stimuli on the cells. 
The other category of gradient generation in microfluidic devices is the diffusion-
based device, in which chemical gradient can diffuse through the membrane or a 
hydrogel. In this method, rapid gradient generation and dynamic gradient profile can not 
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apply to samples. Compared with flow-based gradient generation, diffusion-based 
microfluidic gradient generators are able to remove the shear stress from the samples and 
they can introduce chemical gradients to 3D scaffolds. One of the microfluidic devices 
which use the membrane for 2D cell culturing and studying the gradient diffusion 
consists of two microchannels made out of a polydimethylsiloxane (PDMS), and a porous 
PDMS membrane is sandwiched between the two PDMS layers to create a three-layer 
design 34. This device was used for various biological studies, such as oxygen transport 
across the alveolar-capillary barrier 11, organoid on-a-chip 103, gut-on-a-chip 34, drug 
development, and toxicology 12. Essentially, this design can be used in researches that 
need a barrier for culturing endothelial or epithelial cells and for transferring or diffusion 
of the molecules across samples. Recently, multilayer gradient generator device was 
fabricated that contains hydrogel materials that act as a diffuser platform for generating 
gradient inside 3D cellular structures structure. This design contains two reservoirs from 
which molecules can diffuse into the hydrogel and produce the chemical gradient 104. 
1.3 Effect of chemical and mechanical gradient on biological responses 
Microfluidic chips can apply mechanical cues on living cells and tissues, and as a 
result, they can recapitulate the in vitro model. Mechanical cues can be applied by cyclic 
mechanical strain on the samples or by applying fluidic shear stress. The majority of the 
microfluidic devices are flow-based devices and use the fluidic flow for establishing the 
desired condition within the microchannels. The fluidic flow can lead to shear stress on 
the substrate of the device and the apical surface of the cultured-cells in a monolayer cell 
culture. In addition, the shear stress can be a part of the 3D cellular model for mimicking 
the in vivo condition of the body. In the flow-based microfluidic devices, the integration 
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of fluid shear stress can increase the relevance of the in vitro models 105. The renal model 
was developed using a multilayer microfluidic device, in which the primary rat inner 
medullary collecting duct (IMCD) cells were introduced into the microchannel, and the 
result shows that under fluid shear stress the cell viability was increased compared to the 
stationary group 105.  
As the microfluidic devices can mimic the physiological condition for the in vitro 
studies, it makes them one of the best ways to study the vascular system by culturing 
endothelial cells within the microchannels. To study the effects of hemodynamic 
microenvironment on circulating tumor cells (CTCs), a circulatory microfluidic system 
was designed to mimic the exercise relevant shear stress on cancer cells. In this study, the 
effect of the shear stress on breast cancer cells, cancer cells of the ovarian, lung, and 
leukemic origin were studied The result showed that higher flow-induced shear stress had 
much less damaging effects on leukemic cells. However, higher shear stress caused 
apoptosis of CTCs and prevented metastasis 106. In another study, mouse fibroblast cells 
were exposed to chemical gradient and mechanical cues, and due to the fluidic flow, 
shear stress affects the cellular alignment, mobility velocity, and attachment 107. The 
functionality of the engineered human microvessels in microfluidic can be affected by 
mechanical microenvironment 108.  
Flexible material and membranes can be used to apply cyclic mechanical strain in 
a microfluidic environment. In the multilayer organ-on-a-chip devices with hollow 
chambers on side of the channel, the cyclic strain can be applied by the suction generated 
from the side chambers, which can mimic the function of the breathing, peristalsis, and 
cardiovascular cycling of the organs 11, 38. The vascular mechanical environment can be 
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recreated by using microfluidic devices, and this microfluidic design consists of an array 
of microfluidic channels that are covered with suspended deformable membranes that 
cells were cultured on. The biomechanical conditions of small blood vessels were 
recreated by applying the cyclic strain through the membrane.109.  
Microfluidic devices have also emerged as a robust tool for applying mechanical 
cues to cell cultures 110. Combining the advances in the fabrication of microfluidic 
systems and the possibility of incorporation of organoids and tissue-like cultures in a 
biomimetic environment helped with the realization of organ-on-a-chip and body-on-a-
chip platforms. These devices enable studying the effect of drugs, physical, and chemical 
cues on the viability and functions of cultured cells, tissues, and organoids. For instance, 
in the study of cancer cells’ response to epidermal growth factor (EGF), it has been 
shown that breast cancer cells respond to mechanical stimuli more evidently than 
chemical gradients111, 112. Particularly, the effects of mechanical cues have been reported 
to exhibit in the form of increased cell mortality and decreased cell adhesion due to 
increased shear stress. These effects have been shown in prostate cancer cells113, breast 
cancer cells106, 114, 115, and epithelial ovarian cancer cells116. In addition, the effect of 
shear stress on inducing drug resistance in breast cancer cells has also been 
demonstrated61, 117. Thus, it is highly desirable to develop microfluidic chips that can 
effectively examine the effect of mechanical and chemical stimuli in one single 
platform91, 118. Despite the importance of mechanical stimuli in directing cell behavior as 
discussed above, to date, no robust platform for studying the combined role of chemical 
and mechanical stimuli on cultured cells has been reported. 
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In the current study, we extended microfluidic gradient generators to create 
platforms that can simultaneously generate gradients of mechanical and chemical stresses 
in a single device. In addition, this chip design utilizes microchambers embedded within 
channels to provide space for cell culture and exposes these cells to gradients of 
mechanical shear stress and a chemical treatment. We have effectively proved the 
efficacy of an anti-cancer reagent in cancer cells in a dosage-dependent fashion within 
the microchambers of the device, and more importantly in a synergistic manner with both 
chemical and mechanical gradients. Finally, this result was confirmed in a viability study 
in regular dishes. Furthermore, we have demonstrated that this platform can potentially 
be used for creating co-cultures of cells with various ratios. Collectively, this platform 
will pave the way for drug screening with different stimuli in a controlled 3D 
microenvironment. 
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2 Chapter 2: Gradient Generation Design with Embedded Microchambers 
2.1 Device design 
Considering that microfluidic channels and chambers can also facilitate cell 
culture and growth, in this study we proposed an innovative design that integrates 
chemical gradient generation and cell culture in one platform. To this end, 
microchambers for seeding cells and for drug testing on cultured cells were designed and 
placed after each serpentine channel of the Christmas tree-like design. In another design, 
micropillars were also built into chambers to produce a gradient within the chambers. 
This integration of microchambers enables the screening of chemical gradients in 
controlled individual chambers, and thus provides a potential method for high-throughput 
screening of chemical compounds. In addition, this design also allows for the co-culture 
of different cell types at controlled ratios.  
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Figure 1. Design of microchamber embedded microfluidic device for gradient 
generation and drug screening. (a) COMSOL simulation of microchannel embedded 
Christmas tree (MECT) design in which microchambers are embedded after each 
serpentine microchannel. Gradient is generated across chambers and uniform concentration 
is achieved for each chamber. The chambers number based on their position has 
demonstrated on each microchamber. (b) SEM images of the entire chip (c) SEM image 
showing the serpentine channel and the microchamber. Scale bars: b, 2000 μm; c, 500 μm. 
 
Fig. 1a and 1b show the integrated platform with the microchambers placed after 
the serpentine microchannels, referred to as microchamber-embedded Christmas tree 
(MECT). As illustrated in Fig. 1a, each microchamber has different chemical 
concentrations with the combination of two different media solutions at the two inlets; in 
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the meantime, the concentrations within each microchamber are uniform. To produce a 
gradient within a microchamber, micropillars are built within each chamber to create a 
mixing effect and a non-uniform chemical concentration, as illustrated in Fig. 2a. In this 
design, so-called micropillar-embedded microchambers (MPEM), the micropillar arrays 
form a network of flow resistors to generate gradients. The microchambers for both 
devices are designed to be 1 mm in diameter to accommodate about 1,000 cells. These 
dimensions are also tailored to generate shear stresses on the order of 2-10 Pa at the 
bottom of the chamber as a mechanical stimulus for live cells (to be discussed in the 
following sections). Fig. 1b and 2b show the SEM images of the PDMS chips fabricated 
by soft lithography for the MECT and the MPEM designs, respectively. In addition, SEM 
image of Fig. 1c shows the dimension of the serpentine channel and the SEM image of 
Fig. 2c shows the dimension of the micropillar array (with a diameter of ~80 µm for each 
pillar). It is worth mentioning that the diameter of the micropillar may have an impact on 
fluid mixing and gradient generation within the chamber. The current design is mostly 
determined by the limitations of features aspect ratio on the ease-of-peel-off of PDMS 
microfluidic chips from the silicon mold. 
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Figure 2. Design of the MPEM gradient generator microfluidic. (a) COMSOL 
simulation of the micropillar embedded microchamber (MPEM) design. An overall 
gradient across chambers as well as a local gradient within each chamber are generated. 
The chambers number based on their position has demonstrated on each microchamber.  
(b) SEM image of the entire chip. (c) SEM image of the chamber and the micropillars. 
Scale bars: b, 2000 μm; c inset, 400 μm. 
 
2.2 Microfluidic device fabrication 
The fabrication process mainly consists of two steps: the design and fabrication of 
a silicon mold, and the fabrication of the microfluidic chip. For mold fabrication, a 
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chromium mask coated with a thin layer of SU-8 (Kayaku Advanced Materials, MA, USA) 
was etched using a Laser Writer (Heidelberg DWL-66 FS, CA, USA) and an AZ-400K 
developer (Microchemicals GmbH, Germany) through a chemical reaction. CR-7 
chromium etchant (CYANTEK corporation, CA, USA) was subsequently used to remove 
the chromium layer. To ensure that no photoresist remained, a higher concentration (85% 
water) of AZ-400K developer was used to dissolve the remaining SU-8. To fabricate the 
designed features on the Si wafer, S1813 (Microposit, MA, USA) positive photoresist was 
selected for soft lithography. The photoresist was spin coated on the wafer. Then masked 
aligned on the top surface of the wafer and DRIE were performed to project the features 
on the wafer. Then, plasma etching was done to remove the photoresist.  
The chip is made of polydimethylsiloxane (PDMS) (Sylgard 184, Corning, NY).  
PDMS was mixed with a curing agent in a 1:10 volume ratio and left in a desiccator for 30 
min to degas. The wafer was washed with 99% isopropanol and dried using nitrogen gas. 
To avoid PDMS adhesion to the wafer, Trichloro (1H,1H,2H,2H-perfluorooctyle, Silane 
97%) (Sigma Aldrich, St. Louis, MO) was used as the silane agent. The degassed PDMS 
was poured over the entire mold and It was again placed inside a desiccator for 30 min to 
remove any air bubbles formed during pouring. Finally, the wafer was thermally cured 
inside an oven at 65 ℃ for 2 h. The PDMS fabrication process is illustrated in a schematic 
drawing in Fig. 3. 
22 
 
Figure 3. Schematic of the PDMS microfluidic fabrication. (a) Silicon wafer is washed 
and nitrogen dried. (b) A layer of S1813 photoresist is deposited on the wafer using spin 
coater (c) The fabricated mask is placed on top of the wafer to expose the photoresist to 
the UV light. (d) The exposed photoresist is washed using the developer. (e) DRIE process 
is performed the etch the wafer. (f) The remainder of the photoresist is washed and 
removed. (g) The wafer is silaned and PDMS is poured on the wafer. (h) The PDMS chip 
is peeled off the wafer and inlets and outlet are punched, and the surface is activated with 
oxygen plasma. (i) The chip is bonded to the glass slide using heat treatment.  
 
2.3 Device imaging 
ZEISS LSM 800 confocal microscope (4X, 1.4NA) was used for live and fixed 
cell imaging. All images were captured with ZEN software (ZEN, 2017, Zeiss). Bright 
field images were taken with Nikon Ti2 using NIS-Ar software. All image reconstruction 
and channel alignment were performed using the ImageJ software. 
The PDMS microfluidic chip without the glass slide was used for SEM imaging. 
A thermal treatment was applied to the chip in the oven at 50 °C for 30 min before 
coating to remove excessive humidity and enhance the coating process. Then chromium 
sputter coater (Denton Desk V Sputter) was used to coat a thin layer of chromium on the 
chip for 15 min. The coated chip was fixed to an SEM holder and then inserted into the 
SEM (Hitachi S4700 FE). Low magnification mode with 15 kV was used to image the 
whole chip for the pillar design and serpentine design with 20X and 25X magnification, 
respectively. High magnification mode with 15 kV was used to image one chamber for 
the MPEM and MECT with 130X and 67X, respectively. 
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2.4 COMSOL simulation  
To evaluate the performance of the microchip, a computational fluid dynamics 
(CFD) simulation was developed using COMSOL Multiphysics. “Creep flow” and 
“Transport of Diluted Species” physics were used to model the fluid flow, shear stress, 
and concentration changes in the microfluidic device. For the gradient studies, the inlets 
have different flow rates to show the effect of flow rate and their ratios on the generated 
gradient. However, for the shear stress study, both inlets have the same flow rates to 
study the effect of mechanical stimulation on cell viability. Two flow rates were 
examined to investigate the effect of flow rate on the shear stress. Shear stress was 
calculated by adding the following equation to COMSOL analysis: τ = ?̇?𝛾 × 𝜇𝜇 , where τ is 
the shear stress,  ?̇?𝛾 is the shear rate and 𝜇𝜇 is solution viscosity. Shear rate is calculated by 
the software and viscosity is the fluid property. We assumed water as the fluid for this 
simulation. 
2.5 Chemical gradient generation with embedded microchambers  
We next investigated the capability of the microchamber-integrated microfluidic 
devices in generating tuneable chemical gradients across chambers and within chambers 
in MECT and MPEM designs, respectively. After removing the bubbles from the PDMS 
chip, blue and yellow color dyes were mixed with DI water and flowed into the chip with 
a syringe pump at controlled flow rates and flow rate ratios. After the steady-state is 
reached, the last column of chambers was imaged in a brightfield mode. The RGB-
colored image for each chamber is analyzed to extract the blue color index from the 
centerline of the chamber using a customized MATLAB script. 
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This was demonstrated both experimentally and computationally with three 
different flow rate combinations at the two inlets from top to bottom: 20 µl/min and 10 
µl/min (column (i)), 20 µl/min and 5 µl/min (column (ii)), and 30 µl/min and 5 µl/min 
(column (iii)) in Fig. 6 and 7. The color gradients for other flow rate combinations where 
one inlet flow rate was controlled to be constant are shown in Fig. 4 and 5.  
 
Figure 4. Gradient generation with the MECT microfluidic channels. (a) Testing the 
MECT device with 1:2 ratio of flowrate at the inlets. The inlets were perfused with media 
of two different colors, yellow and blue. Three different combination of flowrates with the 
same ratio were examined: 30/15 µl/min (shown in i1), 20/10 µl/min (shown in ii1) and 
8/4 µl/min (shown in iii1), for each flowrate a zoom-in image of the representative chamber 
(#14) is shown in (2). (b) Testing the MECT device with 1:3 ratio of flowrate at the inlets. 
Three different combination of flowrates with the same ratio were examined: 45/15 µl/min 
(shown in i1), 30/10 µl/min (shown in ii1) and 15/5 µl/min (shown in iii1). (c) Testing the 
MECT device with 1:4 ratio of flowrate at the inlets. Three different combination of 
flowrates with the same ratio were examined: 40/10 µl/min (shown in i1), 20/5 µl/min 
(shown in ii1) and 8/2 µl/min (shown in iii1). (d) Testing the MECT device with 1:5 ratio 
of flowrate at the inlets. Three different combination of flowrates with the same ratio were 
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examined: 45/9 µl/min (shown in i1), 30/6 µl/min (shown in ii1) and 10/2 µl/min (shown 
in iii1). (e) Testing the MECT device with 1:6 ratio of flowrate at the inlets. Three different 
combination of flowrates with the same ratio were examined: 42/7 µl/min (shown in i1), 
30/5 µl/min (shown in ii1) and 9/1.5 µl/min (shown in iii1). Scale bar of the zoom-in 
images are 200 µm. 
 
 
Figure 5. Gradient generation with the MPEM microfluidic channels. (a) Testing the 
MPEM device with 1:2 ratio of flowrate at the inlets. The inlets were perfused with media 
of two different colors, yellow and blue. Three different combination of flowrates with the 
same ratio were examined: 30/15 µl/min (shown in i1), 20/10 µl/min (shown in ii1) and 
8/4 µl/min (shown in iii1), for each flowrate a zoom-in image of the representative chamber 
(#14) is shown in (2). (b) Testing the MPEM device with 1:3 ratio of flowrate at the inlets. 
Three different combination of flowrates with the same ratio were examined: 45/15 µl/min 
(shown in i1), 30/10 µl/min (shown in ii1) and 15/5 µl/min (shown in iii1). (c) Testing the 
MPEM device with 1:4 ratio of flowrate at the inlets. Three different combination of 
flowrates with the same ratio were examined: 40/10 µl/min (shown in i1), 20/5 µl/min 
(shown in ii1) and 8/2 µl/min (shown in iii1). (d) Testing the MPEM device with 1:5 ratio 
of flowrate at the inlets. Three different combination of flowrates with the same ratio were 
examined: 45/9 µl/min (shown in i1), 30/6 µl/min (shown in ii1) and 10/2 µl/min (shown 
in iii1). (e) Testing the MPEM device with 1:6 ratio of flowrate at the inlets. Three different 
combination of flowrates with the same ratio were examined: 42/7 µl/min (shown in i1), 
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30/5 µl/min (shown in ii1), and 9/1.5 µl/min (shown in iii1). Scale bar of the zoom-in 
images are 100 µm. 
 
For the MECT design shown in Fig. 6a (i1, i2, ii1, ii2, iii1, iii2), experimentally, 
solutions with yellow and blue colors were flowed into the inlets at the designated flow 
rates above. Chemical gradients across all chambers in the four columns, denoted by the 
difference in color balance, were evident for all three flow rate combinations. In the 
COMSOL simulation shown in Fig. 6a (i3, ii3, iii3), one chemical solution containing 1 
mol/m3 of a chemical species serves as the input to one of the inlets, and zero 
concentration was delivered to the other inlet at the same designated flow rate 
combinations. A gradient of concentrations was evident for each flow rate combination. 
Moreover, images of the last six chambers were captured and processed to produce a blue 
color profile across the center line of the chamber. This color profile was normalized and 
plotted against the COMSOL simulation data in Fig. 6b. An excellent agreement was 
observed for three flow rate combinations and different ranges of chemical concentration 
can be realized with the three flow rate combinations (0.2 to 1 mol/m3 in Fig. 2bi, 0.5 to 
1 mol/m3 in Fig. 2bii, 0.6 to 1 mol/m3 in Fig. 2biii). The zoom-in images for the last 
chamber are shown in Fig. 6a (i2, ii2, iii2) 
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Figure 6. Gradient generation with the MECT microfluidic channels. (a) Testing and 
modeling of the MECT device in generating gradients with different ratios of flow rates at 
the inlets. The inlets were perfused with media of two different colors, yellow and blue. 
Three different velocity ratios were shown: 20/10 µl/min (shown in column i), 20/5 µl/min 
(shown in column ii), 30/5 µl/min (shown in column iii). For each flow rate, the device 
with the gradient is shown in (1), a zoom-in image of a representative chamber (#14) is 
shown in (2). It is evident that variation in flow rate ratios modifies the chemical gradient 
produced. (3) Comsol simulation of gradient generation in MECT snd MPEM microfluidic 
channel. (b) The comparison of the experimental data and the simulation data for gradient 
generation is shown at three flow rate combinations in (i) (ii) and (iii). The gradient is 
captured with the RGB coloration of each chamber. The plot shows the Blue color index 
for center line of the last column of the device (chambers 13 through 18) normalized within 
0 and 1. Scale bars: 500 μm. 
 
For the MPEM design shown in Fig. 7, with the same experimental process, a 
chemical gradient can be produced across different chambers as well as within the 
individual chambers. These results also agree with the COMSOL simulation data for all 
flow rate combinations, with the blue color profile from experiments plotted against the 
concentrations from the simulation for the last six chambers. Specifically, the chemical 
gradient within each chamber is in a narrower range as compared to the gradients across 
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different chambers. The zoom-in images for the last chamber are shown in Fig. 7a (i2, 
ii2, iii2). It is worth mentioning that both devices were designed to be symmetric and 
were demonstrated as such. 
 
Figure 7. Gradient generation with the MPEM microfluidic channels. (a) Similar to 
Fig 6 (a), the experiments were conducted for the MPEM device at three different flow rate 
combinations: i, ii, iii. (b) Comparison of the MPEM device in gradient generation from 
the experiments and the simulation is shown. Gradient was produced across chambers and 
within chambers. Scale bars: 500 μm. 
 
2.6 Mechanical gradient generation with embedded microchambers 
Our COMSOL simulation of the MECT device showed that the amount of shear 
stress at the bottom of the microchambers, which led to morphological and physiological 
changes, correlates with the flow rate at the inlets of the microfluidic channel, as 
demonstrated by the increase of flow velocity and shear stress from a flow rate of 0.1 
µl/min to 0.2 µl/min (Fig. 8a-c to 9a-c). In addition, shear stress decreased significantly 
from the chambers in the columns close to the inlets (#1, #2, #3) to the chambers close to 
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the outlet (#13, #14, #15, #16, #17, #18) due to changes in the frontal cross-sectional area 
per column and the flow rate per column of chambers.  
 
Figure 8. Shear stress analysis of the microchip at 0.1 μl/min flowrate. (a) Velocity 
magnitude of the microchip at 0.1 μl/min flow rate shows a symmetric distribution with 
higher magnitudes within the channels and corners compared to the chambers. (b) Shear 
stress values of the microchip at 0.1 μl/min flow rate 5 μm from the surface show the same 
trend as the velocity magnitude. The distribution of shear stress is symmetric. (c) Zoom-in 
image of shear stress distribution within the chamber #2. (d) Shear stress distribution inside 
a representative chamber #2 along the drawn line shows that the shear stress is at its 
maximum near the entrance and exit of the chamber and is at its minimum in the center of 
the chamber. 
 
Further, shear stress within the chamber was higher closer to the inlet and outlet 
of the chamber, as shown by the cross-section of the shear stress distribution within 
chamber #2 for both flow rates (Fig. 8c and 9c). Note that the amplitude of the shear 
stress produced by the selected flow rates is captured 5 µm above the bottom surface of 
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the chamber. This is about the thickness of a cell and the values represent the shear stress 
exerted on cell surfaces. With an average of 0.005 Pa for the 0.2 µl/min flow rate, the 
shear stress amplitudes fall within the normal physiological conditions 107, 119. It is worth 
mentioning that the relative flow rate ratio at the two inlets determines the chemical 
gradients within the microchambers as demonstrated in Fig. 6 and 7, while the absolute 
values of flow rates determine the amplitude of the shear stress as shown here in Fig. 8 
and 9.  
 
Figure 9. Shear stress analysis of the microchip at 0.2 μl/min flowrate. (a) Velocity 
magnitude for 0.2 μl/min also shows the same trend as 0.1 μl/min flow rate. (b) Shear stress 
distribution along the centerline of the chamber for 0.2 μl/min compared to 0.1 μl/min 
shows higher values of shear stress with the same distribution.  (c) Zoom-in image of shear 
stress distribution within the chamber #2. (d) Shear stress values along the symmetry line 
in chamber #2 is shown.  
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3 Chapter 3: Drug Screening on Cancerous Cell  
In this chapter, to validate the functionality of the device design and examine the 
synergistic effect of chemical and mechanical stimuli in a single microfluidic chip, we 
used a cancer cell model exposed to anti-cancer drugs and flow-induced shear stress. 
Viability test was performed to quantify the effect of concentration gradient of the anti-
cancer drug in the MECT microfluidic design. This design was chosen because it has 
chambers with larger free space for cell culture, and it is more convenient for biological 
assay readout after the study with staining and imaging. To this end, doxorubicin, an anti-
cancer agent, was flowed into the microfluidic device from one of the inlets. Chemical 
gradient of the drug concentration was produced within each microchamber where A431 
cells are cultured. The fluid flow also produces a mechanical gradient in the form of 
flow-induced shear stress on the apical surface of the cultured cells. It is worth 
mentioning cells are cultured in a 2D monolayer within microchambers for this drug 
screening study. In addition, the ability of the device to perform a co-culturing of cells in 
a 3D environment was also demonstrated via encapsulation of two types of cells in 
hydrogels within the microfluidic channels.  
3.1 Effect of chemical and mechanical gradient on cell viability  
3.1.1 Cell culture 
A431 cells (gift from Prof. Kathleen Green, Northwestern University) and A431 
cells with GFP tagged E-cadherin (gift from Prof. James K. Wahl, University of 
Nebraska Medical Center) are cultured in T75 flasks with DMEM included 10% fetal 
bovine serum (FBS) and 1% penicillin-streptomycin (10,000 Unit/mL) for two days until 
cells reach confluency. Before the experiment, cell culture media was removed, and the 
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flask was washed with PBS for two times. Cells were then trypsinized and suspended for 
use. 
3.1.2 Cell seeding for drug study 
PDMS with a ratio of 1:10 was used to fabricate the microchannels and it was 
bonded to glass slides and cured for 30 min at 80 ℃ inside an oven. Human fibronectin 
protein (Thermofisher) with a concentration of 50 µg/ml was used to coat the surface of 
the glass slide as the bottom layer of the microchannels. Fibronectin was flowed into the 
microchannels by syringes and incubated for 2 h, and the fibronectin-coated 
microchannel was washed with PBS. A mixture of the cells and DMEM was flowed into 
the microchannel with syringe pumps at a flow rate of 30 µl/min. The concentration of 
the cell mixture was about 10 million cells per ml of media. Cell attachment and 
proliferation inside the microchannel was reached by placing the microchannel inside an 
incubator for 24h.  
3.1.3 Drug testing and live/dead assay 
Doxorubicin hydrochloride 98.0-102.0% (HPLC) (Sigma Aldrich, St. Louis, MO) 
with a molecular weight of 579.98 was dissolved in water and was diluted in DMEM 
media. For A431 cells, live-dead staining kit was diluted with PBS and was continuously 
flowed into the chambers with cells for 2 h.  Live-dead kit contains Calcein-AM which 
stains green to the cytoskeleton of live cells and ethidium homodimer which stains red to 
the nuclei of dead cells. Cells were then counted with the ImageJ cell counter module. 
Viability of the cells was calculated as the ratio of the live cells (stained green) over the 
total number of the cell, summation of the live (green) and dead (red) cells within each 
chamber.   
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3.1.4 Cell viability analysis due to the chemical and mechanical gradient 
We next examined the effect of drug concentration and flow-induced shear stress 
on cells seeded within the microchambers. We initially cultured cancer epithelial cells 
A431 at the concentration of approximately 580 cells/well. The cultures were then treated 
with doxorubicin (Dox), commonly known chemotherapy drug blocking the 
topoisomerase 2 enzyme in cancer cells to stop cancer cell growth 120. We examined the 
difference in cell viability for different dosages of Dox across microchambers in the 
device. This data was later compared with studies conducted in petri dishes for 
confirmation. Considering the effect of flow-induced shear stress exerted upon cells from 
the microfluidic flow, we further examined the efficacy of Dox in combination with shear 
stress. 
Taking advantage of the ability of the MECT device in generating a uniform 
gradient within each chamber, we performed a drug screening study with A431 cells 
administrated with control media and Dox. We studied four conditions in Fig. 10: (1) 
cells were stained with a live/dead assay 24 h after seeding without any media flow. This 
serves as the control; (2) cells were perfused by Dulbecco's Modified Eagle Medium 
(DMEM) from both inlets for 12 h before live/dead staining at a flow rate of 0.1 µl/min. 
This experimental condition examined the effect of shear stress on cell viability; (3, 4) 
cells were perfused for 12 h with Dox in DMEM solution (at a concentration of 30 
µg/ml) from the bottom inlet and DMEM only from the top inlet at flow rates of 0.1 
µl/min (3), and 0.2 µl/min (4) for both inlets. Representative images for the studies of 
conditions 1, 2, 3, and 4 are shown in Fig. 10a, b, c, d. These studies were performed 
after the cells had been seeded within the microchambers for 24 h. In addition, cells were 
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perfused with the same condition as (3, 4) but at the flow rate of 0.05 µl/min, and the 
representative images of this condition are shown in Fig. 11.  
 
Figure 10. Drug screening treatment on A431 cells using the microfluidic device. Four 
testing conditions were shown: (a) Cells were stained with a live/dead assay 24 h after 
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seeding as control; (b) Cells were subject to 12 h of flow of DMEM from both inlets before 
live/dead staining. (c, d) Cells were subject to 12 h of flow of DMEM/Dox (at a 
concentration of 30 µg/ml) (DMEM for the top inlet, DMEM/Dox for the bottom inlet) at 
flow rates of 0.1 µl/min (c), and 0.2 µl/min (d) for both inlets. For each condition, 
composite images for live/dead cells (green and red) are shown in (i) and the dead cells 
(red) are shown in (ii). (e) Zoom-in image from the fluorescent image of the dead cells of 
the first column (chambers #1 through #3) for the 0.1 µl/min DMEM/Dox condition, 
showing the increase in the number of dead cells. (f) Zoom-in images from chambers #3, 
#7, #12, and #18 for the 0.1 µl/min DMEM/Dox condition, showing the increase in the 
number of dead cells. Scale bars: a-d, 1000 µm, e, 200 µm, f, 100 µm.  *: p<0.05 compared 
with chamber #13 in the same conditions. 
 
 
Figure 11. Drug screening treatment on A431 cells using the microfluidic device with 
a flowrate of 0.05 µl/min. (a) Composite Fluorescent images for live/dead cells (green and 
red) of the microfluidic device are shown. (b) Shows the dead cells (red). Scale bar: 1000 
µm. 
 
Live/dead assay staining without fluid flow showed that cells were attached with 
well-spread morphology across chambers (Fig. 12), with high viability of an average of 
95% for all chambers as shown in Fig. 10a-i (live cells in green) and 10a-ii (dead cells in 
red). This provided clear evidence that cells within each chamber were viable and the 
device works properly. The effect of shear stress was then examined by perfusion of both 
inlets with a control media, DMEM, at a flow rate of 0.1 µl/min. Overall, slightly lower 
cell viability, at an average of 88%, was observed due to shear-induced cell death (Fig. 
10b-i and 10b-ii). In addition, the cell viability increased from the columns closest to the 
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inlet of the device to the columns closest to the outlets (Fig.10b-i), in agreement with 
COMSOL simulation where the shear stress is higher in the columns close to the inlets 
(Fig. 8).  
 
Figure 12: Zoom-in images from live cells within the chambers of the microfluidic 
device of the control group. (a) Chamber #1, (b) Chamber #5, (c) Chamber #8, (d) 
Chamber #15. 
 
Flowing Dox in combination with DMEM at the inlets produced a chemical 
gradient of Dox across chambers as expected, and this concentration gradient clearly 
induced different cell viability across chambers. For both flow rates of 0.1 µl/min and 0.2 
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µl/min, cell viability decreased significantly from the top chamber of each column, where 
the Dox concentration is the lowest, to the bottom chamber of each column, where the 
Dox concentration is the highest (Fig. 10c and Fig. 10d). In particular, representative 
images in Fig. 10e show a group of zoom-in images of the live/dead staining for 
chambers #13 through #18 in condition 3 (0.1 µl/min DMEM/Dox), clearly 
demonstrating an increase in the number of dead cells from #13 to #18 with an increase 
of Dox concentration. A quantitative data set summarizing all four conditions in five 
replicates in Fig. 13a shows the overall decline of cell viability from chambers #13 to #18 
for the two flow rates with DMEM/Dox combination (conditions 3 and 4), significantly 
different from the controls, while the cell viability remains stable for control with no flow 
and for DMEM only at 0.1 µl/min (both inlets) flow rate (condition 1 and 2). Some of the 
larger error bars in Fig. 13c plots may be due to the difference in cell confluency before 
the drug test experiments due to the difference in the number of cells seeded in the 
chambers throughout different trials. Dox is not affecting cellular secretome and the used 
cells are not known to use secretomes for signaling, therefore it is expected that cells not 
to be affected by the upstream culture, but for the sensitive cells and processes, cells can 
be cultured in one column of the chambers to avoid the upstream secretome interferences. 
Flow-induced shear stress gradient alone induced a non-significant change in cell 
viability, comparing the viability data from condition 2 to condition 1 (Fig. 13a). However, 
we observed a synergistic effect between the drug treatment and shear stress from the 
overall cell viability and the patterns of cells attached within individual chambers after 
drug treatment. First, due to the higher shear stress produced from a higher flow rate in 
condition 4 (0.2 µl/min DMEM/Dox), the overall cell viability in condition 4 is clearly 
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lower than that in condition 3 (0.1 µl/min DMEM/Dox), shown in the representative 
images in Fig. 10c and Fig. 10d as well as the quantitative data in Fig. 13a. Second, within 
a single testing chip, as illustrated in Fig. 13b, shear stress increases in columns of 
chambers close to the inlet, while Dox concentration increases in each column from the top 
chamber to the bottom chamber. Significant cell death induced by a combined effect of 
shear stress and drug treatment can be observed in chambers with higher Dox concentration 
and with higher shear stress, for instance, comparing chambers #3, #7, #12 and #18 in 
condition 3 (Fig. 13c), also shown in the representative images of in Fig. 10f. It is worth 
mentioning that the viability number of those chambers in condition 4 may have been 
skewed by the high detachment rate due to the higher levels of flow-induced shear stress. 
Lastly, there is a clear pattern of flow-induced cell detachment, in chambers #4 through #7 
in Fig. 10c-i and chambers #13 through 18 in Fig. 10d-i, and the pattern shows an 
agreement with the simulation data in Fig. 8c, where regions of higher shear stress have 
less attached and living cells. Statistical analyses were performed using unpaired t-test, and 
statistical significance was determined at p < 0.05.  
According to the COMSOL simulation and the design of the chambers, there is a 
gradient of shear stress distribution on the surface of the chambers, even though the overall 
quantitative study of the cell viability within each chamber can represent the cellular 
response to the synergistic condition. From the result based on condition 4 in Fig. 10, 
higher flowrate can increase the amount of drug in each chamber, which can lead to higher 
number of cell death. Moreover, higher shear stress can also induce a series of signaling 
pathways that can promote cell apoptosis 121.  
39 
 
Figure 13. Cell viability ratio of cells according to drug treatment. (a) Cell viabilities 
in the last column of the chambers in the microfluidic device are shown for no flow, 0.1 
µl/min DMEM/DMEM, 0.1 µl/min DMEM/Dox, and 0.2 µl/min DMEM/dox. (b) 
Illustration of chemical gradient and shear stress gradient across different chambers of the 
four columns. (c) Cell viability from the chamber #3, #7, #12 and #18 in DMEM/Dox 0.1 
µl/min condition. *: p<0.05 compared with chamber #13 in the same conditions. 
 
 It is also worth mentioning that the cell study was carried out on the MECT 
chips, given the similar shear stress profile (Fig. 14), we expect similar outcome using the 
MPEM chips. In addition, the small concentration gradient within the chamber of MPEM 
can be useful in studies involving sensitive biological assays, such as growth factor 
stimulation. In addition, as the cells were cultured in all the chambers, cells in the 
upstream may affect cell in the lower stream through secretion factors. However, as the 
fluid flow applies to the device for generating DOX gradient, the dead cells can be 
washed away from the device and this can reduce the influence on downstream cells. In 
addition, to eliminate this effect, cells can be cultured only one column of chambers or by 
applying the ratio of the flowrates at the inlet of the device in which multiple chambers 
can have a similar chemical condition.   
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Figure 14. Shear stress distribution in the MPEM design chip. (a) Shear stress values 
of the microchip at 0.1 μl/min flow rate. (b) Shear stress distribution within chamber #2. 
 
3.2 Comparison between the microfluidic devices with a petri dish in drug study 
The effect of the Dox concentration on cell viability across different chambers 
was confirmed by a comparative study with drug tests in a petri dish. Viability data with 
DMEM/Dox at the inlets at a flow rate of 0.05 µl/min was compared with Dox treatment 
of A431 cells in static culture. A lower flow rate was chosen to minimize the effect of the 
shear stress on cell detachment and cell death. Representative images of live/dead 
staining after DMEM/Dox flow for the last column (chambers #13 through #18) are 
shown in Fig. 15a. Cell viability data was collected by counting cells stained green and 
red from these chambers. According to simulation data, the concentration of Dox in 
chambers #13 through #18 are: 0 µg/ml, 6 µg/ml, 12 µg/ml, 18 µg/ml, 24 µg/ml, and 30 
µg/ml. These concentrations were applied in static culture and the viability data were 
collected. Representative images of static culture treated with Dox of different 
concentrations are shown in Fig. 15b. The quantitative data presented in Fig. 15c for both 
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studies showed reasonable agreement, verifying the effectiveness of the device in drug 
screening.  
 
Figure 15. Comparison of cell viability with multi-well dish study and microfluidic 
device study.  (a) Fluorescent images of the stained dead cells in the 0.05 µl/min 
DMEM/Dox condition from the last column of chambers, from chamber #13 to #18, are 
placed left to right in this image. (b) Fluorescent images from the multi-well Dox study on 
A431 cells with different concentrations of the Dox: 0, 6, 12, 18, 24, 30 µg/ml, matching 
the concentration in microchambers #13 to #18. (c) Cell viabilities within the chamber of 
the last column of the microfluidic device in the 0.05 µl/min DMEM/Dox condition are 
compared with cell viability of the multi-well study with the same concentrations. Scale 
bars: a, 200 µm; b,100µm. 
 
The proposed chip provides a platform where not only screening of drug dosages 
can be performed in high throughput on small microchambers, but also the synergistic 
effect between mechanical stimulants and chemical compounds can be explored in a 
dosage-dependent manner. The chemical gradients, produced in chambers in the same 
column, and the shear stress gradient, generated due to microfluidic flow across different 
columns from the inlet to the outlet, create a matrix of chambers where the effect of 
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different combinations of chemical and mechanical treatments can be examined. This 
concept is illustrated in Fig. 13b, where arrows point in the direction of increasing shear 
stress and chemical concentration, and our anti-cancer studies clearly demonstrated that 
the increase in dosage and in shear stress synergistically enhanced higher cell death rate. 
This capability can be considered a step forward as compared with devices that only test 
the effect of chemical gradients on organoids and cell cultures122, 123, or studies that only 
examine the effect of shear stress on cancer cells61, 117. It should be noted that the number 
of chambers can be expanded to include more concentrations, while the shape of the 
microchamber can be modified to produce different shear stress profiles. Further, the 
microchambers can be tethered at the bottom onto additional PDMS layers separated by a 
thin porous membrane to introduce additional stimulants, such as other chemical 
compounds or oxygen124-126. This transparent system is compatible with microscopes for 
online imaging from the individual chambers, in which immunostaining of the cultured 
cells can be used for biological assays. In addition, the size of the chambers allows 
electrochemical sensors to be embedded for monitoring the environment and 
functionality of the cultured cells. 
3.3 3D cell encapsulation 
GelMA was used as a hydrogel to encapsulate the cells inside the chambers and 
two types of cells were used to demonstrate the co-culturing. GelMA was synthesized by 
following a previous protocol127-129. Methacrylic anhydride (MA) (Sigma Aldrich, St. 
Louis, MO) was mixed with liquid Gelatin in PBS at a ratio of 1.25% (v/v). 
Subsequently, freeze-dried GelMA was dissolved in PBS and combined with a solution 
of Irgacure 2959 (2-Hydroxy-4′-(2-hydroxyethoxy) -2-methyl-propiophenone) (Sigma 
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Aldrich, St. Louis, MO) and PBS. The final ratio of the photo initiator (PI) was 0.1% and 
the final ratio of the GelMA was 7%130. The optimal ratio of the PI was reached by a 
live/dead study of the cell encapsulation within 7% GelMA crosslinked by different PI 
ratios. The cellular viability result of the optimal PI ratio with respect to UV exposure 
time is shown in Fig. 16.  
 
Figure 16. Viability test on the photo-initiator concentration and UV laser duration. 
(a) This row represents the viability of the encapsulated cells within the GelMA with 0.05% 
(w/v) concentration of PI. (i to iv) shows the duration of the UV laser which were 10, 15, 
20, and 30 seconds, respectively. (b)  This row represents the viability of the encapsulated 
cells within the GelMA with 0.03% (w/v) concentration of PI. (c) This row represents the 
viability of the encapsulated cells within the GelMA with 0.01% (w/v) concentration of PI. 
Scale bars of the images are 100 µm. 
 
Mutants of A431 were the cell lines used for 3D co-culturing (A431-DPNTP, 
A431-S2849GDP)131. Cells were stained with either Hoechst or green cell tracker and 
mixed with the GelMA solution. The final concentration of cells encapsulated in GelMA 
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solution was around 5 million cells per ml. The GelMA-cell mixture was filled into the 1 
mL syringes and flowed into the microchannels with syringe pumps at controlled flow 
rates. Once a stable condition was reached inside the microchannels, the infusion was 
stopped and the GelMA was cured under the UV laser chamber with an intensity of 750 
mW for 30 seconds. 
3.4 3D cell seeding and cell culture within embedded chambers  
In newly developed microfluidic devices, the traditional 2D cell culture practices 
have given way to 3D cell culture schemes to closely recapitulate the microenvironment 
in vivo132. 3D cell culture platforms allow for omnidirectional cellular growth with 
biomimetic cell-cell and cell-extracellular matrix (ECM) interactions133. 3D cell culture 
using hydrogels134, fibrous scaffolds135, and droplet suspensions136 within microfluidic 
devices has demonstrated different drug responses, cell morphologies, and proliferation 
patterns than static 2D cell cultures137. Microfluidic systems have also been utilized for 
creating cellular patterns in 2D and 3D environments127, 138, 139. These devices have 
shown great promise for depositing cells in a highly-defined fashion and over a scale of 
several centimeters. Despite this progress, the capability of such systems for engineering 
co-culture of different cells is not well-explored, especially considering the potential of 
co-cultures exposed to different drug compounds.  
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Figure 17. Schematic illustration of the experimental process of 3D cell encapsulation 
within microfluidic channels. 
 
 
Figure 18. Gradient of 3D-cell encapsulation in hydrogel within the microfluidic 
device embedded with micropillar gradient generator. (a) Fluorescent image of the 
gradient of stained cells with 2 different colors of Hoechst and green cell tracker. (b, c) 
Cell ratio analysis in the third and fourth columns of the chambers of the microfluidic 
device, respectively. Scale bars: a, 1000 µm. 
 
 In this study, we explored the capability of the microchamber-based device in 3D 
cell culture. In drug screening, current microfluidic devices allow only one controlled 
area for cell seeding and interaction with the chemicals. Our goal was to introduce spaces 
within the channels which serve as reaction chambers, and cells seeded within each 
chamber receive different dosages of the chemicals, paving the way for high-throughput 
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drug screening. Furthermore, this design provides a means to seed different cell types for 
co-culture, affording new potentials of screening cell-cell interactions. To this end, two 
types of cells were encapsulated in 7% (w/v) gelatin methacryloyl (GelMA) solution, a 
widely used hydrogel for encapsulating the cells, a containing photoinitiator (PI) at a 
concentration of 0.1% (v/v) that could be crosslinked in situ to provide a 3D micro-
environment. This particular concentration is optimized as shown in (Fig. 10). This 
concentration of GelMA has been successfully used for long term 3D culture of various 
cells130. The GelMA solution was then flowed into the inlets of the MECT and MPEM 
devices at controlled flow rates. Once a steady flow condition was achieved, the solution 
flow was stopped, and a UV light was applied onto the microchambers through a mask to 
crosslink GelMA. Crosslinked GelMA encapsulated cells in a 3D environment within 
each microchamber. This process is illustrated in Fig. 17. 
Fig. 18a shows the 3D cell encapsulation of two types of cells (mutants of 
cancerous epithelial cells, A431) colored with blue and green inside the microfluidic 
device, and a clear gradient of cell ratios can be discerned across chambers in the same 
column. Since the flow rate of the cell mixture from both inlets was the same, 
microchambers had a symmetric distribution of both types of cells across the center line. 
As the zoom-in images of Fig. 19a and 19b show, the distribution of the cells within 
chambers were uniform as compared with experiments carried out in MECT devices (Fig. 
20a and 20b), a proof that the micropillars spread the cells evenly within chambers. A 
clear division of two cell types was visualized from the zoom-in images, as the majority 
of the cells in green were seeded in the bottom half of chamber #10 (Fig. 19a). 
Fluorescent image of the 3D cell encapsulation of MECT design is shown in Fig. 21. 
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Figure 19. Zoom-in image from the representative chambers #10 and #11 of MPEM 
design, respectively. The empty regions in circular shape represent the micropillar 
embedded in the chambers. Scale bar: 100 µm. 
 
 
Figure 20. Zoom-in image from the representative chambers #10 and #11 of MPEM 
design, respectively. Scale bar: 100 µm. 
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 Figure 21. Gradient of 3D-cell encapsulation in hydrogel within the MECT gradient 
generator. (a) Fluorescent image of the gradient of stained cells with 2 different colors of 
Hoechst and green cell tracker. (b) Cell ratio analysis in the third and fourth columns of 
the chambers of the microfluidic device, respectively. Scale bars: a, 1000 µm. 
 
The distribution of the cells is determined by the velocity profile within the 
microchambers of each design (Fig. 22). A quantitative evaluation of the cell ratios for 
the last two columns of the device provided clear evidence of the gradient effect as the 
49 
ratio of blue/green cells drops from 1 to 0 (Fig. 18b and 18c). The MPEM device 
produces a line contact between two regions of cells. This can be useful in studying the 
spatiotemporal distribution of cells at the cell-cell contact in different physiological 
conditions140. 
This study provides a potential support for co-culture systems supplied with 
chemical gradients. In this capacity, cells can be encapsulated in 3D microenvironments 
with hydrogels and flowed into the microchambers with a gradient effect. Once cross-
linked within the microchambers, co-cultures of different cell types and ratios can be 
used in a wide spectrum of drug screening studies. Microfluidics-based co-culture 
systems have been used to study different cell types, including epithelial and stromal cells 
for mimicking prostate cancer behavior141, breast cancer cells with lung cells142, as well 
as intestine and liver cells143. The majority of these studies were focused on 2D co-
culture of cells. The introduction of 3D co-culture with our microchamber system can 
create a microenvironment that is more physiologically relevant. In addition, the 
microchambers with the 3D co-culture can be peeled off from the top PDMS layer after 
cell seeding and gel crosslinking. This creates open microchambers where various 
biological assays can be performed on the co-culture of different cell types and ratios.  
Furthermore, our MPEM and MECT devices could control different ratios of cell 
concentrations to create co-cultures of different numbers of cells. 
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4 Chapter 4: 3D Cell Encapsulation and Skeletal Muscle Tissue 
Engineering 
Microfluidic devices were involved with tissue studies, as mentioned before, 
organ-on-a-chip devices are the devices which can mimic the physiological 
microenvironment with fluidic perfusion over the samples. In this chapter, the MECT 
device was modified and scaled up to be compatible as a device to have integration with 
3D cell culturing and tissue-mimicking environment within the hydrogel. The chemical 
gradient production on the cell culture chambers was used for studying the myogenesis of 
skeletal muscle myoblasts.  
4.1 Device fabrication 
The capability of studying the organ-on-a-chip platform based on the MECT 
microfluidic design was examined, and for this purpose, the design was scaled to five 
times larger than the previous study, which gives us the ability to integrate the 3D 
structures inside the microchambers. In this case, we investigate the gradient generation 
of the scaled microfluidic on differentiating the skeletal muscle myoblast into myotubes 
due to the establishment of the growth factor gradients. 
Microfluidic device was designed and fabricated. Solidworks was used for 
modifying and scaling the previous version MECT into the larger scale for encapsulating 
cells within hydrogels inside the microfluidic cell culture chambers. The modifications 
that were applied for the new design was, adding a bubble trapper after the inlets of the 
device, which would not let the bubbles to flow inside the microchannels and affect the 
gradient generation and cell growth. Further, based on the need and purpose of the study, 
the columns of the microchambers can become open that would provide the ability for 
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encapsulating cells within the microchambers or integration of the device with 
bioprinters. As the design has become larger the previous techniques were not able to 
fabricate the microchannels, due to the limitations that the DRIE method to fabricate the 
mold which has a height of more than 150 µm. To overcome this limitation, the 
microchannel design was printed out of veroclear, using Stratasys Objet 500 Connex3 3D 
printer (Lincoln, USA), then the mold was washed in sodium hydroxide for removing the 
support materials of the printing process from the printed microchannels. Next,  the 
printed microchannel was baked at 80 ̊ C overnight in the oven. The PDMS with the ratio 
of 1:10 were poured over the molds and after degassing the mold, PDMS was cured at 80 ̊ 
C in the oven for 1h. Then, the microfluidic chips were peeled from the mold and after 
plasma treatment, they were bonded to the 3-(Trimethoxysilyl)propyl methacrylate 
(TMSPMA) coated glass slides.  
 
Figure 22. Designs of a scaled microfluidic device with open microchamber for 
gradient generation and tissue study. (a) Solidworks design (b) Image of the fabricated 
device, filled with blue and yellow color dyes. Scale bar: 5mm 
 
Fig. 22a showed the scaled microfluidic channels, which demonstrate the open 
chambers at the last row of the chambers. As demonstrated in Fig. 22a the bubble 
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trappers are included in this design and each bubble trapper have 3 small pillars to catch 
and trap the bubble and prevent the movement of the bubbles into the microchannel. The 
gradient generation in this design is similar to the previous MECT design and the 
serpentines are working as the flow mixers and gradient generators. Fig. 22b represents 
the gradient generation within the device, the process of producing a color gradient with 
color dyes are similar as previously described. As mentioned, this design is the five-time 
enlarged of the MECT design and because of that, the dimensions of the channels and 
microchambers are enlarged with the factor of five.  
In the scaled-up design, the dimension of the microchannels had increased by the 
factor of 5 and the channel size is 500 µm, the height of the channels is 500 µm, the 
diameter of the cell culture chambers is 5 mm, and the height of the closed chambers and 
open chambers are 500 µm and 3 mm, respectively. The difference in the height of the 
open chamber and close chambers are due to the fact that open chambers are having an 
open surface that will provide the ability for printing and cell culturing within the open 
chambers.  
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Figure 23. Microfluidic device holder. (a) Schematic of the device. (b) Image of the 
holder.  
In this design, the cell culturing and cell growth and proliferation should be under 
the closed environment, as a result, the DMEM which has enriched with FBS and PS can 
flow into the channels and let the encapsulated cells to grow and proliferate. To achieve 
the closed and sealed device, the open chambers should seal with another thin layer of 
PDMS. In this platform, we design a device holder, to assemble the parts of the device, 
which are PDMS chip, coated glass slide, sealing PDMS layer, and PDMS gasket for the 
bottom layer of the device. In this holder, the pushers on the top layer of the holder, force 
the PDMS sealing layer to seal and close the open surface of the chambers. With this 
design, according to the type of the study, the position of the open chambers can change, 
and the device is capable of any modification to perform in a variety of conditions.  Fig. 
23a shows the schematic of the holder, and Fig 23b represents the assembled device 
using a holder. In this study, the cell culture within the microfluidic device is not only 
under the fluidic-based condition but also, due to the encapsulation of the cells within the 
hydrogel, the chemical can diffuse through the hydrogel and reach the cells.  
4.2 Gradient-based skeletal muscle differentiation 
4.2.1 Cell culture 
C2C12 mouse myoblast (ATCC, USA) were cultured in T75 flasks with DMEM 
included 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (10,000 
Unit/mL), until reaching the confluency of about 80%, for the experiment they were 
washed with DPBS and trypsinized, then the cells were counted and the needed amount 
of cells were separated into 2mL Eppendorf and after aspiration of the DMEM from the 
cells, they were mixed with GelMA solution. 
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4.2.2 TMSPMA coating on glass slides 
Custom size fabricated glass slide ( Springside Scientific LLC, USA) were placed 
in 10% (w/v) sodium hydroxide (NaOH) overnight, then, glass slides were washed with 
100% ethanol and distilled water. The TMSPMA were poured over the glasses and baked 
at 80 ̊ C overnight, after discarding the TMSPMA from the glasses, they were washed 
with 100% ethanol and distilled water and wrapped in the aluminum foil, and stored at 
room temperature. 
4.2.3 Cell seeding for differentiation study 
PDMS with a ratio of 1:10 was used to fabricate the microchannels and it was 
bonded to coated glass slides and cured for 30 min at 80 ̊ C inside an oven. In this study, 
GelMA was used as a hydrogel for culturing and encapsulating cells in a 3D 
environment. As previously described, GelMA was synthesized and lyophilized 
according to the protocol. The lyophilized GelMA was dissolved in DPBS with the 
concentration of 7% (w/v) and filtered with a 0.22 µm syringe filters. lithium phenyl-
2,4,6-trimethylbenzoylphosphinate (LAP) (Allevi, USA) was used as a photoinitiator 
with a concentration of 0.067% (w/v).  
C2C12 cell line was used for this study, after the cell passaging, trypsinized cells 
were mixed with GelMA solution and a droplet of cell and GelMA mixture were placed 
at the middle of each open microchamber, then each droplet was crosslinked for 20sec 
under the UV. After crosslinking all the GelMA-cell droplets, a microfluidic device was 
placed at the holder and the open chambers were sealed with another layer of PDMS 
which has placed and pushed over the open chambers. Now, that device is sealed and the 
DMEM included 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (10,000 
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Unit/mL) had flowed into the device from the outlet of the device, and the device was 
placed inside the incubator for 2-3 days until the air bubbles disappeared inside the 
microchannels. After 2-3 days of the hydrostatic pressure of DMEM over the device, the 
differentiation media were flowed into the microfluidic device, using a Harvard syringe 
pump. Fig. 24a and b represent the images of the device under the hydrostatic and 
flowing conditions. 
 
Figure 24. Images of the running device. (a) Hydrostatic condition (b) Flowing condition. 
 
4.2.4 Immunostaining  
The cellular morphology and myotube formation were assessed by staining the 
actin filament, myosin heavy chain filament, and cellular nuclei. For the staining,  the 
actin was stained with Alexa Flour 488 phalloidin, myosin heavy chain was stained with 
the antifast myosin skeletal heavy chain antibody (Abcam as51263 antibody), and 
cellular nuclei were stained with DAPI. The staining process begins with fixing the cells 
within the hydrogel with 4% (w/v) paraformaldehyde for 10 min, then cells were 
permeabilized with 0.3% Triton for 10 min. The permeabilized cells were blocked with 
BSA 1% and Tween 0.1% for 1h, then the samples were incubated with phalloidin 
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solution for 45min. For an indication of the myotube formation, the samples were stained 
overnight by incubation with the primary antibody diluted with the ratio of 1:200 within 
1% BSA and 0.1% Tween at 4 ̊ C. Then, the samples were incubated with the secondary 
antibody, Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) (ab150116) diluted with a 
ratio of 1:500 with BSA 1% for 2h. Finally, samples were stained with DAPI for 4min. 
The samples were washed with PBS and imaged using an inverted Zeiss confocal 
microscope.  
4.2.5 Differentiation of C2C12 cells 
In this study, we were aiming to observe the effect of Insulin-like growth factor-1 
(IGF-1) on the myogenesis, differentiation of the C2C12 myoblast into myotubes. IGF-1 
maintains the skeletal muscle mass and function with age 144. The limited regenerative 
capacity of the skeletal muscle tissue is due to the decrease of the production and activity 
of the somatotropin which is a growth hormone and IGF-1 axis 144, 145. IFG-1 is one of the 
main factors of modulating muscle regeneration. IGF-1 modulates the satellite cell 
activation, protein synthesis, myofiber survival, and myogenic differentiation by 
activation of various pathways 146. The over-expression of the IGF-1 can lead to 
increased recruitment of circulating stem cells which can enhance muscle regeneration 
147. The local perfusion of the IGF-1 can lead to down-regulate the inflammatory 
response, and promote the regeneration of the skeletal muscle tissue 148. Also, the 
combination of the IGF-1 and vascular endothelial growth factor (VEGF) promotes the 
functional reinnervation of the skeletal muscle 149. 
In this study, the myogenesis of the skeletal muscle was investigated under the 
different concentrations of IGF-1. The myogenesis was observed over the 7days of cell 
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culture and the result was compared with a control group of culturing which was 
culturing the muscle cells with differentiation serum.   
As mentioned before, the C2C12 cells were encapsulated within the GelMA with 
a concentration of 7%, and the LAP solution with a concentration of 0.067%, and the 
solution of the cells and GelMA were crosslinked in the open chamber of the scaled-up 
MECT. Cells were cultured for 2-3 days under the hydrostatic pressure of the enriched 
DMEM with FBS (10%) and PS (1%). Then, the cultured cells were differentiated with 
the variety of the IGF-1 concentration from 0 to 100 ng/mL, which in this study we 
observe six concentrations, as the cells were cultured on the last column of the device. 
The differentiation media have flowed for 7 days with a constant flowrate of 2 µL/min. In 
this study, the control group was the DMEM enriched with Horse Serum (HS) (2%) (v/v) 
and PS (1%), and the IGF-1 media was DMEM enriched with IGF-1 (100 ng/mL), HS 
(2%), and PS (1%). Each of these two groups was filled in a 60 mL syringes and 
connected to one of the inlets of the device after 2-3 days of hydrostatic culture and 
perfused for about 7days using the Harvard syringe pump, as mentioned before, the 
flowrate of the perfusion was constant during the whole study.  
58 
 
Figure 25. Fluorescent images of the cultured cells after 2days under the hydrostatic 
condition with the microfluidic device. (c) Schematic of the myogenesis of C2C12. 
 
Fig. 25 represents the cellular morphology after day 2 of the hydrostatic culture 
within the microfluidic device. Fig. 25a is the image which has been taken with the 
objective 10X, and Fig. 25b was taken with objective 20X. Fig. 25 shows cell 
proliferation and cellular alignment due to the cell culturing environment. The green 
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color is the Actin which represents the actin filaments and the blue is DAPI and 
represents the nuclei of the cells. These images are the Z-stack image and they are the 
projection of a couple of images which has been taken from the surface of the hydrogel. 
The cell alignment is the early stage of differentiation, as the myoblast culture and 
proliferate, they start to align after each other and by changing a media to differentiation 
media, which in this study we used the DMEM enrich with HS and IGF-1, the cells will 
start the fusion into each other and formation of the myotubes. This process involves the 
recruitment of actin to the plasma membrane. Fig. 25c represents the schematic of the 
myogenesis.  
After day 2-3 of the hydrostatic culture of encapsulated cells, the two 
differentiation media flowed over the samples for 7 days. As mentioned before, the 
concentration of IGF-1 can cause a difference in muscle regeneration. In this device, the 
gradient of the IGF-1 was produced and established over the samples, immunostaining 
images of day 7 after differentiation are demonstrated in Fig. 26. As can be seen, the 
myotubes formation is illustrated and clearly, all the groups have started to generate the 
myotube and the trend of the myotube thickness and density is in favor of the 
concentration of the IGF-1. In these fluorescent images, Myosin Heavy Chain (MHC) 
which is the motor protein of muscle thick filaments is stained with antifast myosin 
skeletal heavy chain antibody and is shown with the color red, the actin filaments have 
stained with Actin and are shown with green color. In addition, the nuclei of the cells are 
stained with DAPI and they are represented with blue color.  
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Figure 26. Fluorescent images of the stained differentiated cells after 7 days of 
perfusion with differentiation media within the microfluidic device. (a) IGF-1 
concentration is 100 ng/mL, (b) 80 ng/mL, (c) 60 ng/mL, (d) 40 ng/mL, (e) 20 ng/mL, and 
(f) 0 ng/mL. (i) The composite image of Actin and DAPI staining. (ii) The composite image 
of MHC and DAPI staining. Scale bars: a-c, 20 µm; d,e, 50 µm; e, 100 µm. 
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The comparison between the control group of the differentiation (IGF-1 free 
media) and the other group, clearly shows the trend of the myogenesis due to the 
persistence of the IGF-1. As can be seen in Fig. 26, the number of the myotubes and 
alignment of the cells is obvious observation through the fluorescent images. The 
analysis of the myotube width, myotube length, and the aspect ratio of the nuclei are 
represented in Fig. 27. The width and length of the myotube have been increased by 
increasing the IGF-1 concentration in the differentiation media, these results are in favor 
of the higher aspect ratio of the higher concentration groups compared with the lower 
concentrations. The difference between the aspect ratio of the nuclei of the cells is due to 
the density of the myotubes and the number of the cells in the myotube that has been 
aligned. As mentioned before, increasing the IGF-1 leads to an increase in the muscle 
regeneration activity and this can cause thicker and longer tubes in the same volume, 
which can lead to the nucleus with higher aspect ratios. 
 
Figure 27. Myotube formation analysis on the samples of the microfluidic device 
differentiation. (a) Schematic of the myotube characterization (b) Myotube width (c) 
Myotube length (d) Nuclei aspect ratio.  
 
62 
To validate the functionality of the microfluidic device, the same conditions of the 
differentiation media were applied to encapsulated C2C12 cells within GelMA in a 
petridish study. The cells were cultured for two days with the enriched DMEM with 
FBS(10%) and PS(1%) after the crosslinking of the encapsulated cells. After two days 
that cells have grown and proliferate and aligned to each other, the media over the 
samples were changed with the differentiation media which contains the DMEM, 
HS(2%), PS(1%), and IGF-1 with the concentrations of 0,20,40,60,80, and 100 ng/mL. 
After 7-8 days of differentiation, cells were fixed and stained with the same protocol as 
previously described.  
Fig. 28 represents the myotube formation after day 8 of the differentiation with a 
variety of IGF-1 concentrations. The trend of the myotube formation is similar to the 
result of the device and the number of the myotubes and alignment of the cells had 
increased by increasing the IGF-1 concentration. The analysis of the myotube width and 
the aspect ratio of the cell nuclei of the petridish study are represented in Fig. 29. The 
trend of the myotube width and nucleus aspect ratio is the same as the device study and 
myotube thickness had increased with the higher concentration of IGF-1 and cells were 
more elongated in the higher concentration of IGF-1 groups.  
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Figure 28. Fluorescent images of the stained differentiated cells after 8 days of cell 
culture with differentiation media in petridish. (a) IGF-1 concentration is 100 ng/mL, 
(b) 80 ng/mL, (c) 60 ng/mL, (d) 40 ng/mL, (e) 20 ng/mL, and (f) 0 ng/mL. (i) The 
composite image of Actin and DAPI staining. (ii) The composite image of MHC and DAPI 
staining. Scale bars: 50 µm. 
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The comparison between the result of the microfluidic device and pertidish study, 
clearly shows that the samples which were under the fluidic flow tend to have thicker 
myotubes. Also, it worths mentioning that the samples of the petridish study were under 
the differentiation media one day more than the samples of the microfluidic device. In 
addition, the skeletal muscle samples in the petridish study, start to detach from the 
substrate after the muscle myotubes got mature and the passive tension within the tissue 
was able to detach the GelMA from the substrate. This detachment was observed in the 
higher concentration groups in the day 4-5 of the study in the petridish. On the other 
hand, the samples within the microfluidic device did not detach from the substrate, even 
as they had thicker myotubes compare with the petridish studies.  
 
Figure 29. Myotube formation analysis on the samples of the petridish differentiation. 
(a) Myotube width (b) Myotube length (c) Nuclei aspect ratio.  
 
By comparing the result of the myogenesis of the C2C12 cells in the device and in 
the dish, it is clearly shown that samples in the device have better myotube characteristics 
compared to the differentiated samples in the dish. As can be seen from the comparison 
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plots in Fig. 30, the myotubes from the device in all IGF-1concentrations are thicker and 
have more elongated nuclei compared to samples in the dish. These improvements could 
be due to the fluid flow that promote myogenesis. The other factor that can promote the 
differentiation is the consistency of the IGF-1 concentration in the device over the 
samples in the dish because of a constant flow of fresh media, since the samples in the 
dish study consume IGF-1 over time and this can lead to a decrease in the IGF-1 
concentration over time.  
 
Figure 30. Compression between device differentiation and dish study. (a) Myotube 
width. (b) Nuclei aspect ratio. 
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5 Chapter 5: Conclusion and Perspective Research 
5.1 Conclusion 
Microfluidic devices are favorable platforms for establishing chemical and 
mechanical stimuli. These features can provide the synergistic effect on the response of 
cells and tissues to various biological assays. In this study, we overcome the knowledge 
gap of combining the chemical and mechanical gradient generation within a single 
device. Embedded microchambers after the gradient generation unit provide a space for 
cell culturing and observation in the case of the various studies which is related to 
producing the gradients. These microchambers are able to produce a varied range of 
chemical and mechanical gradients across the device and also within the single chamber. 
In the MECT design, the uniform gradient across the individual chamber has applied to 
the samples. The design can be used in both 2D and 3D cell culture conditions.  
An anticancer drug gradient was introduced to the skin cancerous cells to provide 
the functionality of the device in the 2D environment. In addition, the ability to produce 
the gradient in a fluidic flow environment was used to study the effect of the various 
concentration of the growth factor on myogenesis of the skeletal muscle tissue in a 3D 
cell encapsulation. The design was scaled-up and modified for 3D cell culture, this design 
was featured with open chambers which gives the device a capability for integration with 
printing and crosslinking of the hydrogels within the open microchambers. These data 
demonstrate the effectiveness of the scaled-up design in operating as high-throughput 
organ-on-a-chip platform  
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5.2 Prospective research directions 
The differentiation study on the 3D encapsulated skeletal muscle cells within the 
microfluidic device will be continued. These results should be replicated at least two 
more times. Furthermore, a separate set of experiments need to be conducted to clarify 
the hypothesis that the result is based on them. The robustness of the IGF-1 concentration 
through the seven days of perfusion and the effect of the IGF-1 concentration on the 
myogenesis of C2C12 myoblast should be tested. A PCR test can be conducted to clarify 
the IGF-1 concentration within the differentiation media. 
Further researches are also needed to clarify the integration of the scaled-up 
device with 3D printers and the ability to move the fabrication steps into an automated 
form. In addition, due to the fluidic flow within the device, different organs can be 
printed inside the device.  These designs can be used to study the crosstalk between 
different organs in regenerative medicine. This design is able to control the chemical and 
mechanical stimuli and be used for co-culturing different cells to interact and support the 
3D scaffolds. These capabilities are sufficient to be used for further applications.  
Moreover, this device can be used for non-tissue engineering studies, such as alternative 
meat production, where the physiological relevance of the organ-on-chip device is not 
strictly required .  
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